All articles
BPC-157: What the Research Shows and What to Know Before Trying It
Reading time:
17 min
Resources
Get expert guidance and a personalized care plan designed around you.
Legal and Regulatory Status
Beyond BPC-157’s efficacy, another key consideration is its current legal and regulatory status.
“Peptides fit in a gray zone from a legal perspective,” Cohen says. “You're not going to find a law that gives a thumbs-up to any peptide at all, other than a GLP-1 that comes directly from a pharmaceutical manufacturer.”
The FDA is moving toward reclassifying BPC-157 and a few other peptides soon, but here’s where it stands as of now.
FDA status
BPC-157 has been classified as a Category II unapproved drug (not a supplement) that is not permitted to be compounded. It has existed in what’s known as the “gray market,” meaning it’s unauthorized but not illegal.
In July 2026, an FDA advisory panel voted to recommend BPC-157 to be added to the list of bulk substances that compounding pharmacies are permitted to use as ingredients in prescribed compounded products, as long as certain conditions are met. Importantly, this does not mean BPC-157 has been approved by the FDA. Proponents say that if implemented, the proposed shift could open the door for more research and safer access to BPC-157 from licensed 503A compounding pharmacies.
Some FDA scientists have urged against this move, stating there’s not enough human trial data on their safety, efficacy, long-term effects, and possible interactions with other medications.
WADA prohibition
In 2022, the World Anti-Doping Agency (WADA) added BPC-157 to its list of unapproved substances. It’s prohibited for use by competitive athletes who are monitored by and must adhere to WADA guidelines in order to complete.
The U.S. Anti-Doping Agency follows WADA rules, stating its position on its website: “Because BPC-157 has not been extensively studied in humans, there is no established safe dose, nor is there any proven efficacy of this compound to treat specific medical conditions. Since BPC-157 is not an approved therapeutic agent in any country, there is no basis for granting a [Therapeutic Use Exemption] for this substance.”
Oral vs. Injectable BPC-157
Many peptides are available only in injectable form, but BPC-157 can also be taken orally. These delivery methods differ in convenience, absorption, bioavailability, and the compound's effectiveness for specific purposes.
Whether a medication is ingested or injected affects the compound’s bioavailability, or how much of it is absorbed and usable for its intended purpose. Typically, injectables tend to have higher bioavailability, as they bypass the digestive system. Oral medications or supplements can get degraded by digestive enzymes and acids, so dosages might be higher to ensure the proper therapeutic amount is received. This is particularly true of many peptides, which aren’t stable enough to survive the GI tract.
“BPC-157 is an unusual peptide as it appears to have meaningful bioavailability orally,” Gray says. “Because amino acids are very fragile and cannot withstand the stomach’s gastric acid, most peptides must be injected to prevent this destruction, such as insulin.”
Oral administration of BPC-157 tends to have the best success for GI indications, Gray says, including IBD, ulcers, mucosal healing, or leaky gut. They’re also more convenient and non-invasive (a particular bonus for people who don’t like needles).
Injectable administration (subcutaneous or intramuscular) has higher bioavailability because it bypasses the GI tract. This type of delivery provides more direct systemic exposure, which may be needed for tendons, ligaments, and musculoskeletal applications, Gray says.
Manufacturing Quality and What to Look for
One of the biggest — and more important — issues surrounding BPC-157 and other unregulated peptides is whether they’ve been safely and responsibly manufactured.
“This is really the darkest question of the industry: How does a consumer even know what they're getting in the vial?” Cohen says. “And the truth is, there's no way to be completely confident that what they're getting is what they're paying for.”
Many, though not all, peptide manufacturers are based outside of the U.S, and there’s little to no oversight of them. This also means there’s no standardization in how these products are made. Cohen says one of the American Peptide Association’s goals is to create manufacturing and third-party testing standards.
Vials can contain fillers, preservatives, endotoxins, or even chemical residues from the manufacturing process. These include the chemical solvents DMF, DCM, TFA, which are used in the synthesis of peptides. Some of these solvents pose health risks and are banned in other countries. Of particular note, TFA is a “forever” PFAS chemical.
Cohen recommends consumers have a legitimate certificate of analysis (COA) that’s available to the public — a lab report that verifies it’s undergone third-party testing. The COA should clearly outline the scope of testing: exactly what’s being tested and how the testing is done.
Cohen shares a list of what companies should be testing and including on its COA:
pH levels
Presence of any endotoxins
Sterility
Purity percentage (ideally, 99% or higher of BPC-157) and what the remaining percentage includes
Materials used to make the glass vials, as some can leach heavy metals
Testing both before and after lyophilization (freeze-drying)
Be wary of companies that can’t produce or don't have a COA. “Any reputable peptide provider will have independent third-party testing that they will happily share, with both the lab and the final product, where you can check purity, potency and sterility,” Gray says. “Additionally, BPC-157 has to be reconstituted with bacteriostatic water that also needs to be sterile and have third-party testing behind it, as well.”
Many peptides are marketed as “for research only” or “research grade,” Cohen says, but those terms are also not standardized and essentially meaningless. Labeling these products as "for research use only and not for human consumption" was an attempt at preventing the FDA from shutting down a manufacturer, Cohen says. “Research grade is not defined,” he says. “It’s a made-up term.”
Side Effects and Safety
BPC-157 and other peptides do need a prescription from a provider (and it’s a giant red flag if a company sells them without requiring one). While the safety profile of BPC-157 appears to be positive, any medication or supplement runs the risk of side effects. It’s difficult to know what those are, however, because of the lack of human clinical trials. For the same reason, there’s no standardized dosage that’s been clinically proven to be effective and also safe.
Another risk is interactions with other medications. “At this point, no drug-peptide interactions have been studied,” Gray says. “Caution may need to be exercised with PDE5 inhibitors and nitrates in individuals with chronic inflammation, taking high doses of BPC. Additionally, any one who is pregnant, lactating, or under the age of 18 should avoid trying peptides.”
Anyone who is immunocompromised or has a history or high risk of cancer should also not take BPC-157 because of its mechanisms of action with angiogenesis, macrophage polarization, and cytoprotection. These effects could potentially promote tumor growth.
BPC-157 vs. TB-500
When taken together, BPC-157 and TB-500 are known as the Wolverine stack. Here’s how these two peptides actually stack up against each other.
BPC-157 | TB-500 | |
Mechanism | Angiogenesis, nitric oxide modulation, cytoprotection | Actin regulation (cell building and dismantling), cell migration |
Primary use | Gut healing, tendon repair | Systemic tissue repair, flexibility |
Route | Oral or injectable | Injectable (limited bioavailability orally) |
WADA status | Prohibited | Prohibited |
Both may offer benefits for repair and recovery, though they target different areas and manner of repair though different mechanisms of action. BPC-157 can be taken orally or as an injectable, which offers more flexibility in its delivery.
It’s important to note that neither BPC-157 nor TB-500 has a substantive body of evidence in support of its efficacy or safety in humans — individually or combined in a stack.
Is BPC-157 right for you?
While it does show a lot of promise, BPC-157 has not been rigorously tested on humans, and it’s not legally available through licensed providers under current FDA guidelines. That status could possibly change soon, but it’s important to thoroughly evaluate the significant legal and safety concerns surrounding it. Anyone considering peptide therapy should speak to their healthcare provider first.
If you’re a WADA-tested athlete, however, use of BPC-157 is a hard no, as it’s in violation of the organization’s position on this peptide.
Gray’s overall summary of the peptide captures its complicated existence: “BPC-157 is a peptide with a very compelling biological story, a strong animal-evidence base, no completed human trials, lots and lots of real-life anecdotal support, possible sourcing concerns, and the potential to really help many people.”
The Bottom Line
BPC-157 shows promise for a variety of functions, but most research is preclinical with no confirmation from human trials. While its status with the FDA appears to be changing to make it more available and potentially better regulated, BPC-157 is currently not FDA-approved.
Always work with a licensed healthcare provider to ensure any peptides are legally prescribed and pharmaceutical-grade. Mochi Health can connect you with licensed providers who will work with you to find treatments and products that are safe and that best fit your needs.
FAQs
Is BPC-157 legal in the United States?
BPC-157 is an unregulated compound that’s not been approved by the FDA. It’s currently prohibited from being manufactured.
What is BPC-157 used for?
BPC-157 is most commonly used for inflammation, gut health, and accelerated recovery of tendons, ligaments, and muscles.
Is BPC-157 banned in sports?
BPC-157 is prohibited for use both in and out of competition by the World Anti-Doping Agency (WADA) and the U.S. Anti-Doping Agency (USADA).
Share this post
Resources
More articles
Read next
For iOS & Android
